Integra Therapeutics appoints Mark Bonyhadi as new independent director

Integra Therapeutics announced today that Dr Mark Bonyhadi has been appointed to its Board of Directors as an independent director. Dr Bonyhadi has more than 30 years of experience in biopharmaceutical leadership roles in the US, specifically in developing commercially viable approaches to take cell and gene therapies and regenerative medicine from the lab to […]